Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Orr-Urtreger A, Giladi N and Mirelman A. Parkinson’s disease phenotype is influenced by the mutation in the GBA gene. Parkinsonism and Related Disorders. 2018. PubMed
Category: Publications
Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?
Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF, Montplaisir JY, and Postuma RB. Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable? Parkinsonism and Related Disorders. 2018. PubMed
Full sequencing and haplotype analysis of MAPT in Parkinson disease and REM sleep behavior disorder
Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, AmbalavananA, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Charley Monaca C, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon JF, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA and Gan-Or Z. Full sequencing and haplotype analysis of MAPT in Parkinson disease and REM sleep behavior disorder. Movement Disorders. 2018; PubMed
LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.
Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Charley Monaca C, Cochen De Cock V, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Mollenhauer B, Sixel-Döring F, Trenkwalder C, Oertel W, Montplaisir JY, Postuma RB, Rouleau GA and Gan-Or Z. LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. Parkinsonism and Related Disorders. 2018 PubMed
Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysms in the French-Canadian population.
Zhou S, Gan-Or Z, Ambalavanan A, Xie P, Bourassa CV, Strong S, Ross JP, Dionne-Laporte A, Spiegelman D, Dupré N, Xiong L, Dion PA and Rouleau GA. Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysms in the French-Canadian population. Scientific Reports. 2018. PubMed
Sleep disorders and Parkinson disease; lessons from genetics.
Gan-Or Z, Alcalay RN, Rouleau GA and Postuma RB. Sleep disorders and Parkinson disease; lessons from genetics. Sleep Medicine Reviews. 2018. Review. PubMed
Alpha galactosidase A activity in Parkinson’s disease.
Alcalay RN, Wolf P, Levy O, Kang UJ, Waters C, Fahn S, Ford B, Kuo SH, Vanegas N, Shah I, Liong C, Narayan S, Pauciulo M, Nichols W, Gan-Or Z, Rouleau G, Chung W, Oliva P, Keutzer J, Marder K and Zhang X. Alpha galactosidase A activity in Parkinson’s disease. Neurobiology of Disease. 2018; PubMed
Mohtashami S, He Q, Ruskey JA, Zhou S, Dion PA, Allen RP, Earley CJ, Fon EA, Xiong L, Dupre N, Dauvilliers Y, Rouleau GA and Gan-Or Z. TOX3 variants are involved in restless legs syndrome and Parkinson disease with opposite effects. Journal of Molecular Neuroscience. 2018; PubMed
Association study of Essential Tremor genetic loci in Parkinson’s disease.
Ross JP, Mohtashami S, Leveille E, Johnson AM, Xiong L, Dion PA, Fon EA, Dauvilliers Y, Dupre N, Rouleau GA and Gan-Or Z. Association study of Essential Tremor genetic loci in Parkinson’s disease. Neurobiology of Aging. 2018. PubMed
Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson’s disease.
Blauwendraat C, Kia DA, Pihlstrom L, Gan-Or Z, Lesage S, Gibbs JR, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Chung SJ, Goldwurm S, Toft M, Schulte C, International Parkinson’s Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hernandez D, Singleton AB, Nalls MA, Brice A, Scholz SW and Wood NW. Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson’s disease. Neurobiology of Aging. 2017. PubMed